Welcome to LookChem.com Sign In|Join Free

CAS

  • or

337340-02-0

Post Buying Request

337340-02-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

337340-02-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 337340-02-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,7,3,4 and 0 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 337340-02:
(8*3)+(7*3)+(6*7)+(5*3)+(4*4)+(3*0)+(2*0)+(1*2)=120
120 % 10 = 0
So 337340-02-0 is a valid CAS Registry Number.

337340-02-0Relevant articles and documents

Design and solid-phase synthesis of chiral acyclic and cyclic diamine ligands

Li, Dehe,Hall, Dennis G.

, p. 1733 - 1736 (2005)

A model resin-bound oligoamide functionalized with a rationally designed non-interfering diamine spacer was reduced with borane-THF to provide the corresponding diamine derivative. The latter was transformed using an efficient orthogonal sequence of trans

Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity

Sagara, Yufu,Sagara, Takeshi,Uchiyama, Minaho,Otsuki, Sachie,Kimura, Toshifumi,Fujikawa, Toru,Noguchi, Kazuhito,Ohtake, Norikazu

, p. 5653 - 5663 (2007/10/03)

Identification of a novel class of potent and highly selective M 3 muscarinic antagonists is described. First, the structure-activity relationship in the cationic amine core of our previously reported triphenylpropionamide class of M3 selective antagonists was explored by a small diamine library constructed in solid phase. This led to the identification of M3 antagonists with a novel piperidine pharmacophore and significantly improved subtype selectivity from a previously reported class. Successive modification on the terminal triphenylpropionamide part of the newly identified class gave 14a as a potent M3 selective antagonist that had > 100-fold selectivity versus the M1, M 2, M4, and M5 receptors (M3: K i = 0.30 nM, M1/M3 = 570-fold, M 2/M3 = 1600-fold, M4/M3 = 140-fold, M5/M3 = 12000-fold). The possible rationale for its extraordinarily higher subtype selectivity than reported M3 antagonists was hypothesized by sequence alignment of multiple muscarinic receptors and a computational docking of 14a into transmembrane domains of M3 receptors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 337340-02-0